Being voted a Best Doctor means a lot to Dr. Susan Stuart, because it means that when it comes to skin care, the San Diego dermatologist is doing something right.

La Jolla, CA (PRWEB) November 8, 2007 -- The reality is Susan Stuart, M.D. didn't just do something right in 2007. She has a track record of doing everything right, beginning with her undergraduate education at Duke University where she was elected into Phi Beta Kappa, a prestigious academic honor bestowed upon but a small fraction of undergrads who achieve the highest standards of scholarship. She didn't stop there, going on to receive her M.D. from Tulane University School of Medicine. Success built upon success, and she soon completed a one-year dermatology research fellowship at San Diego's Mercy Hospital Medical Center.

By Keeping Vitamin A Active Drug Slows Prostate Tumor Growth

A novel compound that blocks the breakdown of retinoic acid, derived from vitamin A, is a surprisingly effective and "promiscuous" agent in treating animal models of human prostate cancer, say investigators from the University of Maryland, Baltimore (UMB).

Daily injections of the agent VN/14-1 resulted in up to a 50 percent decrease in tumor volume in mice implanted with human prostate cancer cells, reported Aakanksha Khandelwal, Ph.D., at the American Association for Cancer Research Centennial Conference on Translational Cancer Medicine. No further tumor growth was seen during the five-week study, Khandelwal reports.

Importantly, VN/14-1 exerted its effects in multiple ways, which is the hallmark of a so-called promiscuous drug, according to the study's senior investigator, Vincent C.O.

Feeling Stressed?

Pending job cuts at the office. Back-to-back final exams. A messy divorce. An unexpected surgery. What do they all have in common? In a word -- stress. While everyone knows that stress can take a toll on a person physically and psychologically, it also can lead to dermatologic problems, such as acne, brittle nails or even hair loss.

Speaking today at the American Academy of Dermatology's Skin Academy (Academy), dermatologist Flor A. Mayoral, MD, FAAD, clinical instructor in the departments of dermatology and cutaneous surgery at the University of Miami's Miller School of Medicine in Miami, Fla., discussed the most common outward signs of stress on the skin, hair and nails, and offered stress management tips to control these symptoms.

"In treating hundreds of patients over the years with skin conditions such as eczema, rosacea, acne and psoriasis, I have seen firsthand how stress can aggravate the skin and trigger unexpected flare-ups that, in effect, create more stress for patients," said Dr.

Skincare Confusion: Skin Care and Scalp Acne

Skincare-News.com discusses scalp folliculitis, a skin condition that can mimic acne by producing white heads and blemish-like bumps on the scalp and hairline.

Mild forms can be treated with skincare products most people already own. Oftentimes, folliculitis may heal its own. On the other hand, severe cases of folliculitis are medical conditions that can lead to hardened, red bumps and this must be treated medically.

A lesson for wannabes: embrace obscurity

Does celebrity turn women mad? Or must you be mad to pursue fame so hungrily in the first place? This was the question hovering above Lady McCartney's spectacular flame-out on GMTV, BBC News 24, US Today, ABC and any other media outlet with available studio time. Highlights of her performance should be played to classes of teenage girls with dreams of WAGdom, every X Factor or reality soap wannabe.

It's a lesson otherwise unteachable, that even if you are beautiful, have acquired the rich husband whose name assures A-list invites, borrowed jewels and Chanel trinkets, and have a huge divorce swag-bag pending, you could end up weeping and railing over scrapbooks filled with cruel words, and be sent ever more sectionable by a chat-show host's wisecrack. And that when you bare your terror, your suicidal thoughts, your outrage at the sheer it's-not-bloody-fair-ness, the world will turn, stare, then laugh its ass off one more time.

All-Natural MicrodermaMitt Deeply-Exfoliates Skin Using Only Water

MicrodermaMitt, Inc. announced today a revolutionary, all-natural, new exfoliating mitt available for consumers who want healthier skin without the use of chemicals or synthetic materials. The MicrodermaMitt® deeply exfoliates safely and effectively to improve the appearance and texture of your skin in just minutes using only water. It gives skin the gentle yet effective treatment it needs to stay smooth, radiant and healthy.

Cincinnati (PRWEB) November 6, 2007 -- MicrodermaMitt, Inc. announced today a revolutionary, all-natural, new exfoliating mitt available for consumers who want healthier skin without the use of chemicals or synthetic materials. The MicrodermaMitt® deeply exfoliates safely and effectively to improve the appearance and texture of your skin in just minutes using only water.

Researchers raise questions about drug being studied as possible MS treatment

TORONTO - A group of American scientists has warned other researchers that an acne drug being tested as a possible treatment for a variety of neurodegenerative diseases - including in Canada for multiple sclerosis - may actually cause harm.

Their report, published Thursday in the journal Lancet Neurology, comes just a week after the Multiple Sclerosis Society of Canada announced it was funding a multi-centre Phase 3 trial to look at whether the inexpensive and off-patent minocycline can slow the progression of MS when treatment is commenced in the earliest stages of the disease.

Bradley Pharmaceuticals 2007 Third Quarter Results

FAIRFIELD, N.J., Nov. 8 /PRNewswire-FirstCall/ -- Bradley Pharmaceuticals, (Nachrichten) Inc. announced today that it has filed with the Securities and Exchange Commission its Quarterly Report on Form 10-Q for the quarter ended September 30, 2007.

Bradley reported that net sales for the quarter ended September 30, 2007 were approximately $33.6 million, a decrease of $1.6 million, or 5%, from net sales of $35.2 million for the quarter ended September 30, 2006.